Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure CC transcript Inv. presentation
|
ISTA PHARMACEUTICALS INC (ISTA)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/04/2012 |
8-K
| Quarterly results |
05/04/2011 |
8-K
| Quarterly results |
11/02/2010 |
8-K
| Form 8-K - Current report |
08/04/2010 |
8-K
| Form 8-K - Current report |
04/30/2010 |
8-K
| Quarterly results |
11/03/2009 |
8-K
| Form 8-K - Current report |
10/30/2008 |
8-K
| Quarterly results |
08/07/2008 |
8-K
| Quarterly results |
04/30/2008 |
8-K
| Quarterly results |
11/01/2007 |
8-K
| Quarterly results |
08/01/2007 |
8-K
| Quarterly results |
04/26/2007 |
8-K
| Quarterly results |
11/02/2006 |
8-K
| Quarterly results |
05/08/2006 |
8-K
| Quarterly results |
02/23/2006 |
8-K
| Quarterly results
Docs:
|
"ISTA Pharmaceuticals, Inc. Reports Fourth Quarter and Year End 2005 Financial Results IRVINE, Calif., Feb. 23 /PRNewswire-FirstCall/ — ISTA Pharmaceuticals, Inc. a specialty pharmaceutical company focused on the commercialization and development of unique and uniquely improved products for serious conditions of the eye, today reported financial results for the fourth quarter and year ended December 31, 2005. ISTA reported net revenue for the fourth quarter and year ended December 31, 2005 of $3.7 million and $10.7 million, respectively. Net product sales for the fourth quarter and year ended December 31, 2005 were $3.6 million and $10.4 million, respectively. Net product sales for the fourth quarter 2005 included Xibrom net sales of $1.5 million, Istalol net sales of $1.4 million and Vitra..." |
|
11/08/2005 |
8-K
| Quarterly results |
08/04/2005 |
8-K
| Quarterly results |
05/10/2005 |
8-K
| Quarterly results |
|
|